| Neuro-Oncology | |
| Former Names: | --> |
| Abbreviation: | Neuro-Oncol. |
| Nlm: | Neuro Oncol |
| Discipline: | Neuro-oncology |
| Editor: | Kenneth Aldape |
| Publisher: | Oxford University Press |
| History: | 1999-present |
| Frequency: | Monthly |
| Impact: | 10.091 |
| Impact-Year: | 2018 |
| Issn: | 1522-8517 |
| Eissn: | 1523-5866 |
| Coden: | NEURJR |
| Lccn: | sn98001441 |
| Oclc: | 40529271 |
| Website: | http://neuro-oncology.oxfordjournals.org/ |
| Link1: | http://neuro-oncology.oxfordjournals.org/content/current |
| Link1-Name: | Online access |
| Link2: | http://neuro-oncology.oxfordjournals.org/content/by/year |
| Link2-Name: | Online archive |
Neuro-Oncology is a monthly peer-reviewed medical journal covering cancer of the nervous system. It was established in 1999 and is published by Oxford University Press on behalf of the Society for Neuro-Oncology. The editor-in-chief is Kenneth Aldape. According to the Journal Citation Reports, the journal has a 2019 impact factor of 10.091.[1]